IL-IFT
9.5.2023 14:01:28 CEST | Business Wire | Press release
The Institute of Food Technologists (IFT), a nonprofit scientific organization committed to advancing the science of food and its application across the global food system, and the Seeding The Future Foundation are proud to announce the return of the annual Seeding The Future Global Food System Challenge. The Challenges invites scientists, engineers, innovators, entrepreneurs, and multidisciplinary teams from non-governmental organizations (NGOs), non-profits, social enterprises, universities, research institutions as well as small and emerging startups to submit their game-changing innovations that will help transform the global food system.
Now in its third year, the Challenge will once again award $1 million in grants and prizes via Seed Grants ($25,000 each), Growth Grants ($100,000 each), and Seeding The Future Grand Prizes ($250,000 each). Last year’s Growth Grant and Grand Prize winners included:
- Commercializing black soldier fly larvae as chicken feed to enhance egg nutrition and lower the cost of eggs in Rwanda. (Food Systems for the Future)
- Eliminating dangerous aflatoxins from smallholder supply chains starting with peanuts in Haiti. (Acceso)
- Accelerating the deployment of aquaponics that combine soilless crop production and fish farming to increase global food production in the face of climate change. (INMED Partnerships for Children)
- Community-led solar powered cold storage program to enable access to improved agricultural techniques and practices in rural developments. (Smart Villages Resource Group)
- Leveraging the US Postal Service to bring fresh produce from farms to front doors. (World Wildlife Fund)
“The Global Food System Challenge is meant to be a call to action to the global food community. More than 840 million people suffer from chronic hunger, severe undernutrition, and extreme poverty while more than 30% of food is wasted globally every year. Climate change, conflicts and poverty prevent equitable access to safe and nutritious food for many populations in both developed and developing regions. We urgently need impactful and transformative innovations that will lead to a sustainable food system and enable access of healthy, affordable, and appealing food that consumers trust,” said Bernhard van Lengerich, founder of Seeding The Future Foundation.
While application submissions open on June 1 and close on August 1, interested participants can review guidelines here to begin preparing their submission.
Since 2021, more than 1,500 submissions from 75 countries have been received from multidisciplinary teams from academic and research institutions, non-profits, and startups. The Challenge is funded by the Seeding The Future Foundation and hosted by IFT.
“The Seeding The Future Global Food System Challenge mirrors IFT’s mission and commitment to addressing food insecurity and ensuring a healthy future for our global food supply,” said IFT CEO Christie Tarantino-Dean. “We are thrilled to be partnering once again with Bernhard and the Seeding The Future Foundation on one of the most important showcases of food innovation and ingenuity.”
For more information, visit ift.org/food-system-challenge. Applicants needing additional support are encouraged to review Frequently Asked Questions.
About Institute of Food Technologists
The Institute of Food Technologists (IFT) is a global organization of approximately 12,000 individual members from more than 100 countries committed to advancing the science of food. Since 1939, IFT has brought together the brightest minds in food science, technology and related professions from academia, government, and industry to solve the world’s greatest food challenges. IFT works to ensure that its members have the resources they need to learn, grow and advance the science of food as the population and the world evolve. IFT believes that science is essential to ensuring a global food supply that is sustainable, safe, nutritious, and accessible to all. For more information, please visit ift.org.
About Seeding The Future Foundation
The Seeding The Future Foundation is a private, non-profit organization motivated by its core value that everyone should always have equitable access to safe, nutritious, affordable, appealing, and trusted food. It seeks to inspire innovative solutions that can help transform the global food system to be more sustainable and benefit the health of people and the environment. The Foundation provides seed funding and support to promising ideas and high impact innovations to improve food systems globally, technologies to reduce post-harvest losses in developing regions, as well as foundational work in academia and research. For more information, please visit seedingthefuture.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230509005101/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
